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Javier López-Zetina, Wesley Ford, Mark Weber, Stefi Barna, Theresa Woerhle,
Peter Kerndt, Edgar Monterroso
Objectives: To describe HIV prevalence and the association between syphilis incidence and
sexual and drug injection risk behaviours in a cohort of street recruited injecting drug users
(IDUs) in Los Angeles County, between 1994 and 1996.
Methods: During the study period, 513 street recruited African-American and Latino IDUs
were screened for syphilis and antibodies to HIV. Subjects were administered a risk behaviour
survey at baseline and followed up at 6 month intervals for 18 months with repeated interviews
and serological screening. Rate ratios were used to examine associations between syphilis
incidence and demographic characteristics and risk behaviours. A proportional hazard model was
used to identify predictors of syphilis incidence independent of demographic characteristics.
Results: 74% of the sample were male, 70% African-American, 30% Latino; and the median age
was 43 years. Overall baseline serological prevalence of HIV was 2.5% and of syphilis 5.7%. None
of the participants were co-infected for HIV and syphilis at baseline or at any of the 6 month fol-
low ups. Among 390 eligible IDUs retained for analysis of incidence data, the overall syphilis
incidence was 26.0 per 1000 person years. Higher syphilis incidence was found for women com-
pared with men (RR=2.70; 95% CI 1.60, 4.55), and for those 44 years of age or younger com-
pared with those 45 years of age and older (RR=2.26; 95% CI 1.25, 4.08). African-Americans
were more likely to be syphilis incident cases when compared with Latinos, although the diVer-
ence did not reach statistical significance (RR=1.27; 95% CI 0.72, 2.23). In bivariate analysis,
risk behaviours significantly associated with higher syphilis incidence included injection of
cocaine, “speedball” and heroin, “crack” smoking, recency of first injection event, backloading of
syringes, injecting with others, exchanging drugs or money for sex, multiple sex partners, and
non-heterosexual sexual preference. Variables that significantly predicted syphilis infection at fol-
low up in the multivariate analysis included multiple sex partners (RR=7.8; 95% CI 2.4, 25.0),
exchanging money for sex (RR=3.0; 95% CI 0.9, 9.6), and recent initiation to injection drug use
(RR=4.6; 95% CI 1.1, 18.8).
Conclusion: Syphilis transmission among IDUs in Los Angeles County remains a serious pub-
lic health concern, particularly among IDUs who engage in trading of sex for money or drugs.
Although low, the prevalence of HIV observed in this study constitutes a serious concern because
of the potential for expanded HIV transmission in this susceptible population of IDUs with high
syphilis incidence. Enhanced case finding screening eVorts and prevention of transmission of
sexually transmitted infections should specifically target hard to reach IDUs and their sexual
partners.
(Sex Transm Inf 2000;76:462–469)
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Introduction
Multiple studies have reported the concurrent
association between injection drug use, HIV
infection, and other sexually transmitted
diseases.1–4 Syphilis, in particular, is increas-
ingly seen as a marker for high sexual risk
behaviour among injection drug users (IDUs).5
Previous studies of syphilis among IDUs have
suggested that while high prevalence of syphilis
and low HIV prevalence are often found in
clinical settings, in drug treatment centres the
reverse pattern of moderately high prevalence
of HIV and low prevalence of syphilis may be
more common.6 In addition to these diVer-
ences in patterns of co-morbidity among IDUs
depending on recruitment settings, pro-
nounced regional variation in the prevalence of
these infections has been observed in this rela-
tively comparable high risk group.7–9 Despite
these diVerences and frequent atypical sero-
logical presentation, syphilis serology screening
among IDUs provides a valuable opportunity
to further our understanding on the epidemio-
logical patterns of indirect transmission of HIV
and other STDs from the injecting to the non-
injecting population. While sustained spread of
syphilis has not been reported in the United
States in recent years, periodic outbreaks of the
infection as well as localised high prevalence
foci remain an important public health prob-
lem.10 Further, the epidemiological and clinical
problems posed by its association with HIV
have important implications for the prevention
and clinical management of the co-
infection.11 12 The role of parenteral transmis-
sion of HIV in the spread of the epidemic
among IDUs has been examined extensively,
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yet little is known about other bloodborne and
sexually transmitted infection interactions in
low HIV prevalent areas.13 Prevalence esti-
mates of HIV infection among IDUs in Los
Angeles County are considerably lower than in
the east coast.14 15 In areas of low HIV
prevalence, the presence of other markers of
parenteral and sexual HIV risk transmission
provides important means to understand the
spread of HIV and to establish prevention
measures.16 17
A steady overall decline in nationwide rates
of primary and secondary syphilis has been
reported during the 1990s, yet, many metro-
politan urban areas continue to experience
increasing number of syphilis cases and dra-
matic disparities still exist among some popu-
lations.12 For example, the US syphilis rate for
African-Americans was almost 60 times greater
than for non-Hispanic white people during this
time period.18 In Los Angeles County, the 3
year average syphilis incidence from 1992 to
1994 was 6.0/10,5 and the county ranked
fourth in the average crude case rate of syphilis
incidence reported statewide between 1992
and 1994.19 Moreover, primary syphilis among
African-Americans in Los Angeles County is
20 times more prevalent than among white
people, and three times more prevalent among
Latinos than white people.20 With the growing
contribution of IDU to the spread of HIV/
AIDS, drug users, particularly IDUs, are thus
an important target for preventing HIV and
syphilis transmission because these infections
share similar risk factors, and because IDUs
are a recognised behavioural population linking
high risk individuals to the non-injecting
population.
This paper reports on factors associated with
syphilis incidence in a cohort of IDUs, followed
over an 18 month period in south central Los
Angeles, and discusses the implications of these
findings for HIV and STD prevention and
control.
Methods
SAMPLE
Participants were recruited as part of a
longitudinal study with a primary focus on
HIV and STDs risk behaviours. Recruitment
took place at Los Angeles County street
locations where IDUs are known to congre-
gate. The study was part of a larger, national,
multisite study of risk behaviours and risk of
HIV seroconversion among IDUs.9 Dynamic
recruitment by word of mouth and street
outreach, and active follow up of participants
began in August 1994 and continued until
August 1996. Open enrolment of eligible
participants continued throughout the first 12
months of follow up. Subjects in the selected
neighbourhoods were invited into the study
using a protocol based on a semistructured
screening interview to determine eligibility.
Only individuals who had injected drugs within
the past 12 months and who were not enrolled
in a drug treatment programme at the time of
the initial interview were eligible to participate.
The three recruitment venues were located in
south central Los Angeles areas where the pre-
dominant racial/ethnic composition is African-
American and Latino. Peer and/or indigenous
outreach workers trained in survey administra-
tion and certified in HIV counselling and phle-
botomy screened, enrolled, and interviewed
participants in a especially equipped mobile
testing unit. After the baseline interview,
participants were actively followed at 6 month
intervals with repeated risk behaviour inter-
views and serological screening.
Follow up of participants was based on a
protocol to ensure ongoing contact with
participants. Features of this protocol included
periodic updates at 3 month intervals of
participants’ baseline locator information (cur-
rent address, telephone number, contact per-
son, etc). Updates were obtained by mail, in
person, or by having participants call a toll-free
phone number. Attempts to locate subjects
who failed to return for scheduled follow up
appointments included ongoing searches at
social services agencies, county jails, and state
prisons, as well as searches of the Los Angeles
County’s death certificate databases. Fifty four
of the 886 follow up interviews were conducted
at county and state detention facilities. By one
evaluation measure of this tracking protocol
(number of participants who returned at least
once after baseline ascertainment into the
study), follow up was moderately successful
with a retention rate of 85%. However, only
37% of the participants were able to complete
all three scheduled follow up interviews.
After written informed consent was ob-
tained, the survey questionnaire was adminis-
tered and serum specimens were obtained by
venepuncture or fingerstick. To minimise
socially desirable responses to risk behaviour
questions, participants were provided with pre-
test counselling following survey administra-
tion. The standardised survey questionnaire
consisted of detailed questions on drug use and
sexual behaviour practices during the previous
6 months. As part of the HIV pretest counsel-
ling, participants were oVered condoms and
bleach kits free of charge. They also were reim-
bursed with a small stipend of $20 to oVset
travel expenses. Study subjects were also
encouraged to return to the interview site the
week following their interview to receive their
serological test results and additional risk
reduction counselling, and were given the
option of calling the toll-free telephone number
to set up an appointment and receive their test
results. In order to defray any other transporta-
tion expenses incurred while receiving their
results, participants were oVered an additional
$5 stipend. Participants were informed that
although HIV test results were to remain con-
fidential, state law required that a positive
syphilis test would be reported to the Los
Angeles County Department of Health Serv-
ices. Upon completion of the intake interview
and phlebotomy, subjects were given appoint-
ment cards to update their locator information
at 3 month intervals and to return for their fol-
low up visit.
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SEROLOGY
Syphilis status was determined by serological
evidence. Specimens reactive to both non-
treponemal test (non-treponemal Rapid Plasma
Reagin-Venereal Disease Research Laboratory,
RPR-VDRL (Hardy Laboratory) and trepone-
mal test (microhaemagglutination-T pallidum,
MHA-TP (Miles Laboratory)), were considered
syphilis cases. By this criterion, subjects were
determined as incident cases if serological
evidence indicated any reactive RPR-VDRL test
with a titre of 1:1 or higher at any follow up visit,
confirmed with a reactive MHA-TP tests, and
non-reactive RPR-VDRL and MHA-TP tests,
and no history of syphilis reported at baseline.
The syphilis screening research protocol at the
Los Angeles County Public Health Laboratory
consisted of a simplified algorithm whereby
specimens reactive to RPR-VDRL tests were
then confirmed by the MHA-TP test; and no
MHA-TP testing was performed on sera from
participants who tested non-reactive on the
RPR-VDRL test. Ascertainment of syphilis was
carried out exclusively by serology screening,
and no clinical information was collected in this
study. However, study subjects were asked
whether they have previously been diagnosed
with syphilis and whether or not treatment was
received. Given the absence of clinical infor-
mation, incident syphilis cases could not be
staged accurately, although based on the sero-
logical data, date of reactive tests, and surveil-
lance definitions cases may be considered early
latent cases according to self reported history of
syphilis and their midpoint of seroconversion
(median 8.6 months; range 5.1–18.2 months).21
In addition to the assessment of syphilis serore-
activity, serum specimens were tested for the
presence of antibodies to HIV-1 by enzyme
linked immunosorbent assay (ELISA), and con-
firmatory western blot (OTC Laboratories).
ANALYSIS METHODS
The incidence of syphilis infection was esti-
mated as incidence density—that is, the
number of new infections divided by total per-
son years of follow up. The dynamic cohort
study design resulted in variable lengths of fol-
low up; therefore, incidence was calculated as
the number of new syphilis infections divided
by 1000 person years of observation. The sero-
conversion date was estimated as the midpoint
between the baseline negative result and the
first positive result. Subjects who failed to
return for any given scheduled follow up
appointments contributed person year data up
to their most current follow up return visit (if
any), and the corresponding 6 month interval
risk behaviour data were used in conjunction
with the most recent test result. Participants
with only baseline data were excluded from
incidence tabulation but the data analysis
methodology utilised all available time data by
including in the analysis all participants with at
least two data points—that is, baseline and any
follow up visit. In addition, five participants
with serological evidence of treated syphilis at
baseline were also retained in the incidence
cohort but their serological profile remained
unchanged at follow up.
Demographic variables and risk behaviour
variables were collapsed to permit a meaning-
ful analysis of the data. With a median of 43
years, participants in this study formed an
older cohort of IDUs, and baseline age was
classified in two age groups (<44 v>45 years).
Other demographic variables were categorised
as follows: marital status (married v not
married), educational status (high school
graduate or beyond v less than high school),
homelessness, and sources of most income in
the past 6 months (illicit income—that is, theft,
drug sales, sex trade v legal full or part time job
or welfare assistance). Similarly, risk and sexual
behaviours ascertained at follow up were strati-
fied according to these categories: injection of
any drug in the past 6 month (yes v no),
“speedball “and heroin injection frequency
(never v once daily v more than once daily),
cocaine injection frequency (once daily or less
v never), “crack” smoking, backloading of
syringes (sometimes v never), recency of first
injection (<5 v > 5 years), age at first injection
(< 25 v > 26 years), sites of “shooting up”
(transient which includes abandoned building,
shooting galleries, car, dealers’ apartment v
non-transient which includes own or spouse’s
apartment or friend’s/relatives’s place), and
injecting with other people (always v some-
times v never).
Self reported sexual risk behaviours at follow
up were categorised as follows: multiple sex
partners (> two partners v < one partner,
range of first category two to 210, mean 11.8),
and exchanging drug, or money for sex (yes v
no). Self reported sexual orientation—
ascertained at baseline—was dichotomised in
two groups (behavioural sexual group A) com-
posed of heterosexual IDUs, and (behavioural
sexual group B) comprising men who have sex
with men, bisexual men, and lesbian IDUs.
Risk behaviours significantly associated in the
bivariate analysis were further examined in a
Cox proportional hazards model to identify
factors independently associated with syphilis
incidence. Interval censoring of the data was
utilised to account for participants lost to
follow up (that is, study subjects who never
returned after their baseline ascertainment into
the study), participants with missing baseline
serological data, and baseline prevalence cases.
Statistical analyses were performed with SAS for
Windows 6.10.
Results
Five hundred and fifty nine IDUs were
recruited from the street venues in Los Angeles
County from August 1994 to October 1996.
Owing to the extremely small sample size of
participants who were white (3.8%) or who
reported “other” race/ethnic category (3.3%),
the analyses described here were restricted to
African-Americans and Latinos (513/559).
Eighty five per cent of baseline eligible study
subjects (436/513) completed at least one
follow up visit, 65% completed at least two
visits, and 37% completed three follow up
visits. Participants lost to follow up did not dif-
fer significantly by race, age, marital, or
educational status although they were more
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likely to be male and homeless. Seventy four
per cent of the sample were male, the median
age was 43 years (range 18–70 years), 70%
identified themselves as African-American, and
36% as homeless. Approximately three in five
(63%) reported regular part time or full time
employment as their main source of income
during the preceding 6 months while the rest
engaged in illicit activities to obtain money
(that is, theft, drug sales, sex trade, etc). At
baseline, 60% of participants reported an edu-
cational attainment of high school or beyond.
Most participants (99%) reported heroin as the
injection drug of choice, followed by speedball
(63%) and cocaine (34%), and 74% reported
smoking crack in the past 6 months. More than
half of the participants were polydrug users,
with 52% reporting use of at least two injection
drugs and smokable crack.
BASELINE SEROLOGY
Overall prevalence of syphilis, and HIV at
baseline by demographic characteristics is
shown in table 1. At baseline, the prevalence of
syphilis was two times greater than that of HIV.
None of the participants was co-infected with
HIV and syphilis. In general, female IDUs
exhibited a greater prevalence than males for
the two serological outcome measures, with
syphilis prevalence among females twice that of
males. By race/ethnicity, African-Americans
showed a higher prevalence when compared
with Latino participants. Among white IDUs
the prevalence of syphilis was 11% (2/18) but
no incidence was observed in this racial/ethnic
group. Subsequently, they were excluded from
further analysis because of their unstable small
sample size. By reported source of income,
those who reported illicit sources of income
showed a twofold diVerence in prevalence of
syphilis when compared with participants with
regular employment. People who considered
themselves homeless showed a greater preva-
lence of syphilis and HIV, although the
diVerences were less pronounced.
SYPHILIS INCIDENCE
Syphilis incidence by selected demographic
characteristics is shown in table 2. Three hun-
dred and ninety participants were retained in
the analysis of syphilis incidence after exclusion
of participants lost to follow up (77 out of 513
cases with only baseline data), subjects with
incomplete syphilis serological data (20 out of
436 cases with no serum specimen for syphilis
testing), and syphilis prevalent cases who did
not experience a repeated syphilis episode (26
out of 416 cases). The median length of follow
up was 8.6 months among syphilis incident
cases, and 17.0 months among non-incident
cases. The cumulative syphilis incidence dur-
ing the study period was 3.1%. With 461.1
person years of observation calculated from
390 participants, overall incidence was 26.0
cases per 1000 person years. Women, those
under 44 years of age, African-Americans,
homeless people, and IDUs who reported illicit
sources of income were more likely to be inci-
dent cases, although race/ethnicity and home-
less status comparisons failed to reach statisti-
cal significance.
Among injection risk behaviours, injecting
with other people, injecting in transient and/or
public places, as well as recent initiation to
injection use were significantly associated with
a greater risk of becoming infected with syphi-
lis (table 3). Among heroin users, a gradient of
greater heroin use and greater risk of becoming
infected with syphilis was observed with a rate
ratio of 2.9 for those who injected more than
once daily, and 1.2 for those who injected once
daily or less, compared with those who did not
inject heroin during the preceding 6 months.
However, most participants were polydrug
users and no discernible pattern of risk was
observed when any use of speedball, cocaine,
and heroin was examined. Independent of drug
of choice, injection drug use was significantly
associated with syphilis, although the associ-
ation was only marginally significant (RR =
Table 1 Serological prevalence of syphilis and HIV at baseline among street recruited
injection drug users in Los Angeles County, 1994–6
Demographic characteristics
Syphilis HIV
Cases/total
sample % Positive
Cases/total
sample % Positive
Overall prevalence 28/487 5.7 13/513 2.5
Sex:
Female 12/128 9.3‡ 4/137 2.9
Male 16/359 4.4 9/376 2.3
Age (years):
<44 23/294 7.8‡ 9/308 2.9
>45 5/193 2.5 4/205 1.9
Race:
African-American 22/336 6.5 12/360 3.3
Latino 6/151 3.9 1/153 0.6
Educational status:
< High school 15/198 7.5 4/207 1.9
> High school 13/289 4.4 9/306 2.9
Marital status:
Married 7/94 7.4 1/101 0.9
Not married 21/393 5.3 12/412 2.9
Homeless:†
Yes 12/180 6.6 5/184 2.7
No 16/303 5.2 8/325 2.4
Source of most income:*†
Illicit sources 15/185 8.1 5/192 2.6
Regular employment 13/301 4.3 8/320 2.5
*See text for definition.
†Total varies because of missing data.
‡p<0.05.
Table 2 Syphilis incidence among injection drug users in Los Angeles County, 1994–6
Demographic characteristics
Cases/total
sample
Incidence
rate/1000
person years
Rate
ratio 95% CI p Value
Overall incidence 12/390 26.0 — 19.4, 32.3
Sex:
Female 6/106 48.1 2.7 1.60, 4.55 <0.01
Male 6/284 17.8
Age (years)
<44 9/227 34.2 2.2 1.25, 4.08 <0.01
>45 3/163 15.1
Race:
African-American 9/269 27.8 1.2 0.72, 2.23 >0.05
Latino 3/121 21.8
Educational status:
> High school 8/233 29.5
< High school 4/157 20.8 0.7 0.40, 1.23 >0.05
Marital status:
Not married 10/318 26.7 1.2 0.68, 2.08 >0.05
Married 2/72 22.4
Homeless:
Yes 3/183 31.6 1.2 0.75, 2.17 >0.05
No 9/306 24.6
Source of most income:*
Illicit sources 8/105 67.3 5.7 3.30, 9.85 <0.01
Regular employment 4/282 11.8
*See text for definition.
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1.5; 95% C.I. 0.84, 2.75). Similarly, crack
smoking was also associated with greater risk
for syphilis infection; however, when crack
smoking was analysed independent of injection
use, new infections were observed only among
those who reported the concurrent use of
injection drugs and crack smoking, and no
infections were observed among those who
reported crack smoking exclusively.
In general, indicators of high risk drug injec-
tion behaviours (shooting up in public places,
injecting with other people, recent initiation to
injection drug use) were associated with
increased risk for syphilis, but the only
association between syphilis incidence and
actual needle sharing was observed among
those reporting syringe backloading (RR=2.18;
95% C.I. 1.3, 3.5), a proxy measure of frequent
sharing of drug paraphernalia.
The mean number of sexual partners during
the preceding 6 months, reported by syphilis
prevalent and incident cases, was 13.7 and 43.0
partners, respectively. In contrast, the mean
number among syphilis-free cases after follow
up was two partners. Behaviours associated
with sex trade (exchanging money or drug for
sex) and having multiple sex partners (number
of partners > one partner) showed an increased
risk for syphilis (table 4). By self reported
sexual orientation disclosed at baseline, behav-
ioural sexual group B (homosexual and bi-
sexual men and lesbian women) showed a
10-fold increased risk for syphilis when com-
pared with the behavioural sexual group B
(heterosexual IDUs). Of the four incident cases
from behavioural sexual group B, one identi-
fied himself as a homosexual male, two as
bisexual women, and one as a transsexual bio-
logical male. Only one of the incident cases
(included in the tabulation of incidence)
reported a history of syphilis, and having been
treated for it in the past 6 months.
Injection and sexual risk behaviours identi-
fied as significant correlates of syphilis inci-
dence in the bivariate analysis were further
examined in a multivariate analysis which
included time to first infection in the model. A
Cox proportional hazards model with interval
censoring at the time of the last visit, and base-
line demographic characteristics (sex, age, and
race), dates of baseline, and last serological
screening or first occurrence of a syphilis event,
and separate risk behaviour factors was utilised
to observe the independent association be-
tween risk behaviours and syphilis. Time to
first event was defined as the number of
months elapsed from a negative baseline
screening to first occurrence of a syphilis infec-
tion. The strength of the association was deter-
mined by hazard ratios and corresponding 95%
confidence intervals. Multiple sex partners
(HR = 7.8; 95% C.I. 2.4, 25.0), exchanging
money for sex (HR = 3.0; 95% C.I. 0.9, 9.6),
and recent initiation to injection drug use (HR
= 4.6; 95% C.I. 1.1, 18.8) appeared as predic-
tors of incident syphilis infection independent
of demographic characteristics in the multi-
variate model (table 5). Predictors in this
model were further examined by adding inter-
action terms to the regression model. Two
interaction terms were evaluated separately,
one encompassing number of sexual partners
and sexual orientation; and a second interac-
tion term that examined number of sexual
partners and sex trade. Both models with the
interaction terms failed to reach statistical sig-
nificance (p <0.67 and p <0.55, respectively).
Discussion
The primary finding is that injection drug users
recruited through street based outreach in Los
Angeles County have a high incidence of
syphilis. The incidence of syphilis reported in
similar populations elsewhere in the United
Table 3 Syphilis incidence among injection drug users by self reported IDU risk
behaviours in the past 6 months, Los Angeles County, 1994–6
Injection risk behaviours
Cases/total
sample
Cases/1000
person years
Rate
ratio 95% CI p Value
Overall incidence 12/390 26.0 — 19.4, 32.3
Injected any drug:
Yes 11/343 27.3 1.5 0.84, 2.75 >0.05
No 1/42 17.9 1.0
Speedball injection:
More than daily 1/26 35.8 1.1 0.73, 1.92 >0.05
Daily or less 2/113 15.4 0.5 0.27, 0.93 <0.01
Never 9/246 30.2 1.0
Cocaine injection:
Daily or less 3/52 52.5 2.3 1.42, 3.71 <0.01
Never 9/331 22.8 1.0
Heroin injection:
More than daily 8/187 39.2 2.9 1.60, 5.23 <0.01
Daily or less 3/143 16.8 1.2 0.60, 2.54 >0.05
Never 1/56 13.5 1.0
Crack smoking:
Sometimes 9/200 39.1 3.0 1.66, 5.51 <0.01
Never 3/190 12.9 1.0
Backloaded syringe:*
Sometimes 4/72 47.2 2.1 1.33, 3.58 <0.01
Never 7/273 21.6
Recency of first injection:
5 years or less 3/22 128.7 6.2 4.18, 9.42 <0.01
More than 5 years 9/368 20.5
Sites of shooting up:
Transient 3/81 32.5 1.3 0.78, 2.23 >0.05
Non-transient 9/308 24.5
Injected with other people:
Always 2/58 32.4 1.8 1.03, 3.26 <0.05
Sometimes 8/240 28.2 1.6 0.88, 2.89 >0.05
Never 2/89 17.6
*Total varies because of missing data.
Table 4 Syphilis incidence among injection drug users by self reported sexual risk
behaviour in the past 6 months, Los Angeles County, 1994–6
Sexual risk behaviours
Cases/total
sample
Cases/1000
person years
Rate
ratio 95% CI p Value
Overall incidence 12/390 26.0 — 19.4, 32.3
Multiple sex partners:
Yes 7/120 50.2 3.2 1.89, 5.54 <0.001
No 5/269 15.5
Exchanged money/drugs for sex:
Yes 5/55 77.7 4.4 2.76, 7.12 <0.001
No 7/335 17.5
Sexual orientation:
Group B* 4/22 187.4 10.3 7.0, 15.2 <0.001
Group A† 8/367 18.1
*IDU men who have sex with men, and bisexual and lesbian IDUs.
†Heterosexual IDUs.
Table 5 Risk factors for syphilis seroconversion among injection drug users in Los Angeles
County, 1994–6
Risk factor
Unadjusted ratio Adjusted ratio*
HR 95% CI p Value HR 95% CI p Value
Multiple sex partners 8.0 2.5, 25.4 <0.01 7.8 2.4, 25.0 <0.01
Recent initiation to IDU 6.7 1.7, 25.4 <0.01 4.6 1.1, 18.8 <0.05
Exchanged money for sex 3.0 0.9, 9.4 <0.05 3.0 0.9, 9.6 0.06
HR = hazard ratio.
95% CI = 95% confidence intervals.
*Adjusted for sex, race, and age group.
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States is markedly lower that the one reported
for this IDU cohort. For example, a similar
study of IDUs recruited at a methadone main-
tenance programme in New York found a
syphilis incidence of 2.9/103 person years
among IDUs who remained HIV-free during
the study period,22 in contrast with the Los
Angeles incidence of 26.0/103 person years.
The prevalence of early latent syphilis preva-
lence in the two Los Angeles County health
districts where the study was conducted was
97.2/105 and 59.6/105 in 1993, substantially
higher prevalence than the county average of
19.3/105 for the same year.20 Although county-
wide syphilis have been on the decline since
1989, syphilis incidence appears to be increas-
ing in smaller, local communities within
certain county areas, a pattern also observed in
other large metropolitan areas.23 Undiagnosed
syphilis infections may be considerable,24 par-
ticularly in hard to reach, high risk populations
like IDUs. Asymptomatic clinical profile of
primary syphilis infections,25 and lack of ready
access to health care may contribute to the rise
in syphilis and other bloodborne diseases,
especially in areas with inadequate health
infrastructure to identify cases and provide
treatment.
In the context of the observed twofold
increase in syphilis in the general US popula-
tion from 1985 to 1990,26 sex diVerences in
syphilis incidence were consistent with other
studies that showed a greater likelihood for
infection with syphilis among female IDUs,27
and more specifically, among female IDUs who
engaged in exchanging money and/or drug for
sex.28 29 The results of the multivariate analysis,
however, suggest that new syphilis infections
were associated with sexual risk factors like
trading money for sex, and total number of sex
partners, independent of sex. In this respect, it
may be argued that the observed greater likeli-
hood of syphilis incidence among women is
influenced primarily by IDU mediated risky
behaviours, particularly in closeknit networks
of injection drug users.30 In a population of
IDUs with a homogeneous high risk profile, the
role of drug mediated increased exposure to
HIV and STDs may comprise one of the most
important contributing factor to the spread of
syphilis and other STDs among women.
Significant progress in the prevention and
treatment of syphilis has been made over the
past decades; however, the number of IDU
related and sexually transmitted HIV infections
among women continues to rise steadily, and
renewed eVorts are needed to understand pat-
terns of co-morbidity and transmission of both
HIV and syphilis. Our data corroborate the
well established finding that sexual contact,
particularly that associated with commercial
sex, plays a primary part in the spread of syphi-
lis among IDUs, with T pallidum transmission
particularly higher among IDUs who smoke
crack.31 Multiple studies have previously re-
ported the relation between crack smoking and
greater risk for sexually transmitted infec-
tions,32 yet little is known about the specific
interaction of crack smoking and injection drug
use among polydrug users. However, the inde-
pendent contribution of crack use to greater
risk for syphilis and HIV among IDUs who
engaged in paid sex remains an area for
increased eVorts to reduce risk. Clearly,
prevention eVorts must go beyond the provi-
sion of sterile injection equipment and include
a prevention programme addressing the needs
of polydrug users.
Although HIV prevalence in this population
of IDUs was low when compared to that
reported during the same period in other areas
of the United States, particularly the east coast,
the high incidence of syphilis suggests that
conditions exist for rapid spread of HIV in this
group. Prevalence and incidence levels of
STDs may be seen as precursors of HIV infec-
tion when increased transmission of the HIV
virus is experienced in a susceptible popula-
tion. Neither HIV seroconversion nor HIV and
syphilis co-morbidity were observed during the
follow up span of the study in this cohort of
IDUs. The reported lack of knowledge of
syphilis exposure among incident syphilis
cases, along with the high number of sexual
partners reported, raises serious concerns
about the potential for rapid horizontal spread
of these infections to non-IDUs.31
Several studies, including the present one,
have examined the relation between syphilis as
a marker for greater risk for HIV seroconver-
sion,33 and there is increasing evidence that
co-morbidity with syphilis and bloodborne
infections is common among IDUs, and IDUs
with one of these serological markers infections
show a greater likelihood of carrying the other
markers.3 33 34 However, the short span of the
present study might have resulted in inconclu-
sive data about whether syphilis is an appropri-
ate HIV marker.35 36
The apparent paradox of low HIV preva-
lence, rare HIV seroconversion, and high
syphilis incidence among IDUs in Los Angeles
County reported in this study may be the
results of markedly diVerent IDU milieu and
social context where injection drug behaviour
takes place when compared to other regions in
the United States. This study’s cohort of street
recruited IDUs was an older group and despite
their continued injection drug use and high
prevalence of injecting drug behaviours, they
may represent a cohort of “survivors” who on
account of their low density networks and low
geographic mobility have remained unexposed
to the HIV virus. While shooting galleries were
an ubiquitous features of the IDU milieu in the
east coast, IDUs in Los Angeles reported little
use of such venues. Only 7% in our sample
reported injecting in shooting galleries in past 6
months. Some studies have suggested that in
low HIV prevalence areas exposure to IDUs
from high prevalence areas may be better
predictor of seroconversion than specific IDU
behaviours.37 In contrast with the low HIV
prevalence among IDUs in the districts where
the study was conducted, syphilis appears to
have taken a greater foothold in these areas. As
mentioned above, the magnitude in the diVer-
ence in 3 year average syphilis incidence in the
specific health districts where the study was
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conducted and the rest of the county was two-
fold and threefold.
Study limitations should be considered when
interpreting our findings. Firstly, our sampling
strategy was based on convenience recruitment
of study participants at three sites in Los Ange-
les County; thus, generalising these results to
the larger population of IDUs in the area (esti-
mated to fluctuate between 80 000 and
200 000)8 is not possible. However, given the
well known diYculties of obtaining probability
based samples from this population; the ethno-
graphic, targeted recruitment protocol of this
study provides data on a hidden population not
easily accessible by random sampling mecha-
nisms. Secondly, substantial losses to follow up
in this cohort may bias the data and lower our
estimates because those participant lost to fol-
low up were more likely to be homeless and
male. The present data, however, fill an impor-
tant gap in our knowledge concerning IDUs,
HIV, and STDs, as previous studies have been
primarily based on subjects recruited at drug
treatment centres,32 38 public health clinics,3 5 or
institutionalised populations.39 40 Further, as
the contribution of IDU to the spread of the
HIV/AIDS epidemic continues to grow, under-
standing the role of indirect exposure to HIV
remains a critical factor for the establishment
of STDs and HIV prevention measures.
Another significant caveat in this study is that
syphilis serology alone presents important
limitations for the diagnosis of syphilis and
remains even more problematic owing to the
varied serological response among infected
individuals who inject illicit drugs,11 41 and the
limitations of treponemal tests to diVerentiate
between new infections and those previously
treated for syphilis.42 Owing to the lack of addi-
tional clinical information among syphilis cases
in our study, it may be argued that IDUs with
reactive syphilis serology at follow up might
have been the result of a false positive test (as
evidenced by the weak titre reactions of less
than 1:4 in three out of every four incident
cases), and positive treponemal tests resulting
from previous exposure to and/or treated
syphilis.
Despite these limitations, findings from this
study support the notion that given the poten-
tial increased susceptibility to HIV infection
among IDUs with syphilis reported in other
studies,12 29 reduction of high risk sexual
behaviour and of risky injection drug use
should be incorporated in innovative STD pre-
vention programmes. Targeted prevention,
particularly among IDUs not accessing tra-
ditional drug treatment programmes or those
lacking access to community STD clinics and
facilities, should be an integral component of
these eVorts. Estimates of unidentified syphilis
cases in the United States are high,24 and the
rise in syphilis observed among residents in
inner cities43 calls for renewed screening eVorts
to decrease the spread of STDs and other
infectious diseases in disadvantaged communi-
ties. Tailored interventions that provide con-
dom and bleach kits to IDUs should become
an integral component of preventive eVorts
aimed at the control of HIV and STDs in the
community. Syphilis case finding among IDUs,
particularly those not in treatment, could be
enhanced by utilising creative community
based outreach programmes that provide
testing and preventive counselling to this
hidden population.
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